IN THE SPOTLIGHT

Lung cancer treatment by stage explained

Lung cancer treatment by stage explained

Tarlatamab Gets Priority Review for Advanced Small Cell Lung Cancer

Tarlatamab Gets Priority Review for Advanced Small Cell Lung Cancer

The current status and future of ADC therapy for small cell Lung Cancer: a promising approach

The current status and future of ADC therapy for small cell Lung Cancer: a promising approach

Unlocking New Horizons in Small-Cell Lung Cancer Treatment: The Onset of Antibody–Drug Conjugates

Unlocking New Horizons in Small-Cell Lung Cancer Treatment: The Onset of Antibody–Drug Conjugates

Novel Therapies for Small Cell Lung Cancer and Neuroendocrine Tumors

Novel Therapies for Small Cell Lung Cancer and Neuroendocrine Tumors

Trodelvy May Provide Benefits in Extensive-Stage Small Cell Lung Cancer

Trodelvy May Provide Benefits in Extensive-Stage Small Cell Lung Cancer

Toripalimab Plus Chemo Dubbed New Standard First-Line Therapy for ES-SCLC

Toripalimab Plus Chemo Dubbed New Standard First-Line Therapy for ES-SCLC

Types of Lung Cancer: Knowing the Differences and Treatment Options

Types of Lung Cancer: Knowing the Differences and Treatment Options

Current knowledge of small cell lung cancer transformation from non-small cell lung cancer

Current knowledge of small cell lung cancer transformation from non-small cell lung cancer

Some patients with small-cell lung cancer can benefit from PARP inhibitor with immune checkpoint blockade

Some patients with small-cell lung cancer can benefit from PARP inhibitor with immune checkpoint blockade